Table 2 Patient characteristics and symptomatic DVT
From: Clinical relevance of heparin-PF4 complex antibody in DVT after total joint replacement
Characteristics | DVT(-) n = 88 | DVT(+) n = 16 | p-value |
|---|---|---|---|
Age (years), mean (SD) | 66.9 (12.5) | 73.8 (5.4) | 0.04 |
Gender (male/female) | 16/72 | 1/15 | 0.24 |
BMI (Kg/m2), mean (SD) | 24.9 (4.4) | 25.7 (4.1) | 0.42 |
Metabolic diseases, n(%) | 36 (40.9) | 7 (43.8) | 0.83 |
Hypertension | |||
Diabetes | |||
Hyperlipidemia | |||
History of thrombosis | 0 | 1 (6.3) | - |
TKA/THA | 46/42 | 10/6 | 0.08 |
Primary diseases | 16/72 | 2/14 | 0.54 |
(RA/OA) |